Selution SLR Sirolimus-Eluting Balloon for Femoropopliteal Artery Lesions in Patients With and Without Diabetes: 3-Year Results From the SELUTION SFA Japan Trial
The SELUTION SFA Japan trial demonstrated that among Japanese patients with femoropopliteal artery disease, treatment with the Selution SLR sirolimus-eluting balloon (SEB) resulted in favorable clinical outcomes regardless of diabetic status, with a 3-year primary patency rate of approximately 80%, according to a study presented by Dr. Ehrin J. Armstrong, Swedish Medical Center, Denver, Colorado, USA, in the Late-Breaking Clinical Trials session at VIVA 2025.
- Free Registration
-
Already have an account?Log In
A portal site of complex catheter intervention techniques
TCROSS NEWS Global is an online medical journal that provides
valuable information on Cardiovascular medicine to medical professionals
worldwide.
We bring you the latest findings and trends in all areas of
cardiovascular medicine. Please register and subscribe for unlimited access to
quality Cardiovascular News!
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.
